Phenotypic and functional characterization of CD8+ T cell clones specific for a mouse cytomegalovirus epitope

Virology

Volumn 255, Issue 1, 1999, Pages 40-49

  Fernandez, Jorge A ^a   Zavala, Fidel ^a   Tsuji, Moriya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; IMMEDIATE EARLY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY; LYMPHOCYTE CLONE; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SUPPRESSOR CELL; VIRUS REPLICATION;

EID: 0033102433     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9575     Document Type: Article

References (40)

1. Ando K., Guidotti L. G., Cerny A., Ishikawa T., Chisari F. V. CTL access to tissue antigen is restrictedin vivo. J. Immunol. 153:1994;482-488.
2. Baron J. L., Madri J. A., Ruddle N. H., Hashim G., Janeway C. A. Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
3. Crumpacker C. S. Ganciclovir. N. Eng. J. Med. 335:1996;721-729.
4. Del Val M., Hengel H., Hacker H., Hartlaub U., Ruppert T., Lucin P., Koszinowski U. H. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 176:1992;729-738.
5. Del Val M., Schilcht H-J., Messerle M., Reddehase M. J., Koszinowski U. H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends of its neighboring residues in the protein. Cell. 66:1991a;1145-1153.
6. Del Val M., Schilcht H-J., Volkmer H., Messerle M., Reddehase M. J., Koszinowski U. H. Protection against lethal CMV infection by a recombinant vaccine containing a single nonameric T cell epitope. J. Virol. 65:1991b;3641-3646.
7. Goodrich J. M., Bowden R. A., Fischer L., Keller C., Schoch G., Meyers J. D. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann. Int. Med. 118:1993;173-178.
8. Hanshaw J. B. Congenital cytomegalovirus infection. Pediatr. Ann. 23:1994;124-128.
9. Heise M. T., Virgin H. W. IV. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:1995;904-909.
10. Herstenstein B., Hampl W., Bunjes D., Wiesneth M., Duncker C., Koszinowski U. H., Heimpel H., Arnold R., Mertens T. In vivoex vivo. Bone Marrow Transplant. 15:1995;387-393.
11. Ho M. Observations from transplantation contributing to the understanding of pathogenesis of CMV infection. Transplant. Proc. 23:1991;104-108.
12. Hudson J. B., Missa V., Mossmann T. R. Cytomegalovirus infectivity: Analysis of the phenomenon of centrifugal enhancement. Virology. 72:1976;235-243.
13. Jonjic S., Del Val M., Keil G. M., Reddehase M. J., Koszinowski U. H. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J. Virol. 62:1988;1653-1658.
14. Li C. R., Greenberg P. D., Gilbert M. J., Goodrich J. M., Riddell S. R. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood. 83:1994;1971-1979.
15. Lucin P., Jonjic S., Messerle M., Polic B., Hengel H., Koszinowski U. H. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumor necrosis factor α J. Gen. Virol. 75:1994;101-110.
16. Merrifield B. Solid phase synthesis. Science. 232:1986;341-347.
17. Miller W. J., McCullough J., Balfour H. H. Jr., Haake R. J., Ramsay N. K., Goldman A., Bowman R., Kersey J. Prevention of cytomegalovirus infection following bone marrow transplantation: A randomized trial of blood product screening. Bone Marrow Transplant. 7:1991;227-234.
18. +. J. Immunol. Methods. 181:1995;45-54.
19. Mocarski E. S. Jr. Cytomegaloviruses and their replication. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 2447-2492.
20. Mutter W., Reddehase M. J., Busch F. W., Buhring H-J., Koszinowski U. H. Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in immunocompromised host. J. Exp. Med. 167:1988;1645-1658.
21. Norment A. M., Salter R. D., Parham P., Engelhard V. H., Littman D. R. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature. 336:1988;79-81.
22. Papadopoulos E. B., Ladanyi M., Emanuel D., Mackinnon S., Boulad F., Carabasi M. H., Castro-Malaspina H., Childs B. H., Gillio A. P., Small T. N., Young J. M., Kerman N. A. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330:1994;1185-1191.
23. Pavic I., Polic B., Crnkovic I., Lucin P., Jonjic S., Koszinowski U. H. Participation of tumor necrosis factor α in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:1993;2215-2223.
24. Reddehase M. J., Jonjic S., Weiland F., Mutter W., Koszinowski U. H. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory lymphocytes derived from latently infected donors. J. Virol. 62:1988;1061-1065.
25. Reddehase M. J., Mutter W., Koszinowski U. H. In vivo. J. Exp. Med. 165:1987;650-656.
26. Reddehase M. J., Weiland F., Munch K., Jonjic S., Luske A., Koszinowski U. H. Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:1985;264-273.
27. Renard V., Romero P., Vivier E., Malissen B., Luescher I. F. CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding. J. Exp. Med. 184:1996;2439-2444.
28. Reusser P., Riddell S. R., Meyers J. D., Greenberg P. D. Cytotoxic T lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus disease. Blood. 78:1991;1373-1380.
29. Riddell S. R., Watanabe K. S., Goodrich J. M., Li C. R., Agha M. E., Greenberg P. D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:1992;238-241.
30. +. J. Immunol. 158:1997;1268-1274.
31. +Plasmodium yoelii. Int. Immunol. 3:1990;579-585.
32. +. J. Exp. Med. 175:1992;895-905.
33. Romero P. J., Tam J. P., Schlessinger D., Clavijo P., Gibson H., Barr P. J., Nussenzweig R. S., Nussenzweig V., Zavala F. Multiple T helper epitopes of the circumsporozoite protein ofPlasmodium berghei. Eur J. Immunol. 18:1988;1951-1957.
34. Steffens H-P., Kurz S., Holtappels R., Reddehase M. J. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J. Virol. 72:1998;1797-1804.
35. Stoddart C. A., Cardin R. D., Boname J. M., Manning W. C., Abenes G. B., Mocarski E. S. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:1994;6243-6253.
36. Van Oers N. S., Garvin A. M., Davis C. B., Forbush K. A., Carlow D. A., Littman D. R., Perlmutter R. M., The H-S. Disruption of CD8-dependent negative and positive selection of thymocytes is correlated with a decreased association between CD8 and the protein kinase, p56 lck. Eur. J. Immunol. 22:1992;735-743.
37. Volkmer H., Berholet C., Jonjic S., Wittek R., Koszinowski U. H. Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by a recombinant vaccinia virus. J. Exp. Med. 166:1987;668-677.
38. Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clone from the donor. N. Eng. J. Med. 333:1995;1038-1044.
39. Widmann C., Maryanski J. L., Romero P., Corradin G., Valdimori D. T helper epitopes enhance the cytotoxic response of mice immunized with MHC-class I-restricted malaria peptides. J. Immunol. Methods. 155:1992;95-99.
40. Yang X., Hayglass K. A simple, sensitive dual mAb based ELISA for murine gamma interferon determination: Comparison with two common bioassays. J. Immunoassays. 14:1993;129-148.